PAVmed (PAVM) EBIT (2016 - 2025)
PAVmed's (PAVM) quarterly EBIT came in at -$6.8 million in Q4 2025, down 31.15% year-on-year from -$9.9 million in Q4 2024, and down 40.44% quarter-over-quarter from -$4.8 million in Q3 2025.
PAVmed (PAVM) EBIT (2016 - 2025) Analysis & Trends
PAVmed's EBIT history runs 10 years deep, the most recent figure standing at -$6.8 million for Q4 2025.
- On a quarterly basis, EBIT fell 31.15% year-over-year to -$6.8 million in Q4 2025; TTM through Dec 2025 was -$21.8 million, a 55.76% increase from a year earlier, with the FY2025 full-year figure at -$21.8 million, up 50.98% from the prior year.
- EBIT declined to -$6.8 million in Q4 2025 per PAVM's latest filing, from -$4.8 million in the prior quarter.
- Across five years, EBIT topped out at -$4.7 million in Q2 2025 and bottomed at -$24.6 million in Q4 2022.
- The 5-year median for EBIT is -$14.0 million (2024), against an average of -$14.2 million.
- Across the five-year window, EBIT tumbled 160.44% in 2021 and jumped 68.34% in 2024, its largest moves.
- Year by year, EBIT stood at -$19.7 million in 2021, then declined by 25.01% to -$24.6 million in 2022, then soared by 33.41% to -$16.4 million in 2023, then soared by 68.34% to -$5.2 million in 2024, then tumbled by 31.15% to -$6.8 million in 2025.
- Per Business Quant, the three latest PAVM EBIT figures stand at -$6.8 million (Q4 2025), -$4.8 million (Q3 2025), and -$4.7 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 255.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 515.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 282.15 Mn |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 | -6.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.80 Mn |
| Sep 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.72 Mn |
| Mar 31, 2025 | -5.45 Mn |
| Dec 31, 2024 | -5.19 Mn |
| Jun 30, 2024 | -13.68 Mn |
| Mar 31, 2024 | -14.04 Mn |
| Dec 31, 2023 | -16.38 Mn |
| Sep 30, 2023 | -15.53 Mn |
| Jun 30, 2023 | -16.48 Mn |
| Mar 31, 2023 | -20.40 Mn |
| Dec 31, 2022 | -24.60 Mn |
| Sep 30, 2022 | -23.37 Mn |
| Jun 30, 2022 | -23.48 Mn |
| Mar 31, 2022 | -19.64 Mn |
| Dec 31, 2021 | -19.68 Mn |
| Sep 30, 2021 | -13.67 Mn |
| Jun 30, 2021 | -12.97 Mn |
| Mar 31, 2021 | -8.08 Mn |
| Dec 31, 2020 | -7.56 Mn |